Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_957c5959bd13853a53ebe2918d88f5d2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177da8a88a021859be247242a5f4eacb |
publicationDate |
2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008233090-A1 |
titleOfInvention |
Method of Treatment by Administration of Rna |
abstract |
A method of effecting a treatment response in a target tissue of a subject, comprising: administering to the subject isolated RNA comprising an RNA sequence extractable or extracted from a source tissue such that said treatment response is effected; wherein the RNA is isolated polyA positive RNA in substantially pure form. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9717760-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012321723-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011014161-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105395-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011005930-A1 |
priorityDate |
2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |